Inamed Settlement

Judge Pointer approved a limited fund settlement with Inamed; which means no claimant can opt out of the settlement. The Plaintiffs' Steering Committee(PSC) had the financial resources investigated by Ernst & Young LLP in order to satisfy themselves that the settlement was fair and in the best interests of women who received Inamed breast implants.

The implants covered by the Inamed Settlement are Biocell, Biodimensional, Biospan, Cox Uphoff, CRV/CRS(Creissans Versafil Low Profile), DRI, DRIE, EHP(Enhanced High Profile), FZV/SFV(Round Versafil LP Tissue Expander), Gibney, Intrashiel, (manufactured after 8/2/84), Intravent, IOC(Cylindrical Intraoperative Tissue Expander), IOM(Intravent Intraoperative Expander), IOS(Spherical Intraoperative Tissue Expander), Magna-Site, Maxwell, McGhan(manufactured after 8/2/84), MFE(Man Facelift Expander), Microcell, OHP(Oval High Profile), OLP(Oval Low Profile), RCP(Round Conical Profile), RCR(Ruiz-Cohen Expanders), RDD(Reserve Double Lumen DRIE), RDL(Reverse Double Lumen), RDL-XPAND, RDX(Round Double Lumen), Reverse Double Lumen, RHD(Round High Profile), RHP(Round High Profile), RLD(Round Low Profile DRIE), RLP(Round Low Profile), RTV/RTT(Smooth/Textured), Ruiz-Cohen, RZV/SRV(Rectangular Versafil Tissue Expander), SCC (Cylindrical Tissue Expander), SCS(Crescent Tissue Expander), SEE(Mini-Crescent Tissue Expander), SFS(Saline Fill Skin and Tissue Expander), SGO(Saline Gel Oval), SGR(Saline Gel Round), SLP(Single Lumen Adjustable), SLS(Longitudinally Curved Tissue Expander), SOE(Small Oval Tissue Expander), SOS(Ear Shaped Tissue Expander), SPS(Pear Shaped Tissue Expander), SRS(Rectangular Tissue Expander), SSS(Spherical Tissue Expander), SWS(Wedge Shaped Tissue Expander), SZR(Round Low Profile Sizer), TLL(Triple Lumen Round), Tri-Lumen, TRL(Tri-Lumen Implants), TSO(Triple Lumen Low Profile Oval), TSR(Triple Lumen Round Low Profile), UHP, Ultra High Performance, Versafil, 3M, McGhan (manufactured before 8/3/84), Intrashiel(manufactured before 8/3/84), Natrashiel.

The terms of the settlement involve payment of $32 million into an Inamed Settlement Fund. Distribution of the settlement funds was by equal pro rata distribution to all claimants whose claim forms were received by the Claims Office by October 1, 1999 in the amount of $725.00.